CACLP - The largest IVD Expo & Conference

Devyser Compact achieves Class III approval in China

Industry news | 29 October, 2024 | CACLP

Original from: Devyser

 

Devyser has achieved a significant regulatory milestone with its first market registration from China’s National Medical Products Administration (NMPA) for Devyser Compact, an IVDR-certified genetic test for detecting fetal chromosomal abnormalities. Rapid prenatal aneuploidy detection kits fall under Class III IVD as part of the NMPA product registration process. This approval enables Devyser to market Devyser Compact as an in vitro diagnostic in China and paves the way for future regulatory approvals in the region for its simple, fast, and accurate genetic testing solutions.

 

"Devyser has been engaged in extensive efforts to obtain regulatory approval for its products, and it’s therefore great to see that after several years of hard work, we have successfully obtained market registration in China. Based on this regulatory approval, we are optimistic about the potential of this product in China. This first product approval by the NMPA gives us confidence that several more products will be approved in the future in China. I am very proud of the team who made this happen," says Devyser's CEO, Fredrik Alpsten. 

 

Devyser Compact is IVDR-certified and measures the most common chromosomal abnormalities, such as Down syndrome, and also includes patented technology for safe detection of Turner syndrome. Devyser's single-tube kit is easy to use, requires minimal manual handling, provides fast results and reduces the risk of mixing samples. Utilizing a single-tube PCR process minimizes hands-on time, reduces the risk of sample mix-up, and allows laboratories to efficiently analyze chromosomes 13, 18, 21, and XY with 26 highly informative genetic markers. This patented technology enables accurate, reliable diagnoses, including a dedicated method for Turner syndrome detection. Its streamlined, low-DNA-requirement workflow is fully validated under IVDR, offering labs a fast, standardized solution for critical prenatal insights. Devyser Compact is now the leading standard for prenatal diagnosis in several European countries.  

 

Source: Devyser Compact achieves Class III approval in China

Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference